PRE-VENT Study in Hospitalized Patients With Severe COVID-19 With or Without Cancer
Part of paid clinical trials in Orange, California.
- Sponsor
- CTI BioPharma
- Study ID
- NCT04404361
- Phase
- PHASE2
- Status
- Terminated
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Pacritinib — DRUG100 mg capsules
- Placebo — DRUGPlacebo capsules matching pacritinib 100 mg capsules
Study Details
This is a Phase 2 randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of pacritinib in hospitalized patients with severe COVID-19 with or without cancer.
Key Dates
- Start date
- May 22, 2020
- Status verified
- May 2024
- Primary completion
- Sep 21, 2021
- Completion
- Sep 21, 2021
Study Design
- Enrollment
- 200 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Pacritinib and SOCPacritinib 400 mg once daily \[QD\] on Day 1, then 200 mg twice daily \[BID\] from Day 2 to Day 14) + SOC
- Placebo Comparator: Placebo and SOC4 capsules once daily \[QD\] on Day 1, then 2 capsules twice daily \[BID\] from Day 2 to Day 14) + SOC
Primary Outcome Measure
Percentage of Participants With Progression to IMV and/or ECMO or Death [ Time Frame: Baseline to Day 28 ]
Locations (21)
Find similar trials in Orange, CA
By condition
By specialty
By research site
Related Studies
- Viral Infections in Healthy and Immunocompromised HostsRecruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Bethesda, Maryland
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruiting · Massive Bio, Inc. · Birmingham, Alabama
- Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT StudyPHASE3 · Recruiting · Ansun Biopharma, Inc. · Duarte, California
- Positron Emission Tomography (PET) Imaging of ThrombosisPHASE1 · Recruiting · Massachusetts General Hospital · Boston, Massachusetts